Randomized trial · people

Linaclotide beat placebo for chronic constipation in 12-week trials

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In two large placebo-controlled trials, linaclotide helped more people with chronic constipation reach regular bowel movements over 12 weeks, with diarrhea as the side effect that stood out.

Kind
Randomized trial
Studied in
People
Number studied
1276
Published
2011
Journal
N Engl J Med

What they tested

The teams wanted to know whether linaclotide, taken once a day, works and is safe for people with chronic constipation.

How the study was done

Two randomized, double-blind, placebo-controlled trials at many centers, together enrolling 1276 patients with chronic constipation. Each patient got placebo (a dummy treatment), the 145 μg arm or the 290 μg arm once a day for 12 weeks.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking linaclotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

The main goal was reaching a weekly target of complete spontaneous bowel movements (CSBMs), along with a rise from each patient's starting level, in at least 9 of the 12 weeks. In Trial 303 and Trial 01, this goal was met by 21.2% and 16.0% in the 145 μg arm and by 19.4% and 21.3% in the 290 μg arm, compared with 3.3% and 6.0% on placebo. Both linaclotide arms also did better than placebo on every secondary measure. Side effects were similar across groups except diarrhea, which made 4.2% of patients in both linaclotide arms stop treatment.

What it doesn’t show

Each trial lasted only 12 weeks, so long-term risks and benefits were not tested. The trials were funded by Ironwood Pharmaceuticals and Forest Research Institute.

The paper

Lembo et al. Two randomized trials of linaclotide for chronic constipation. N Engl J Med. 2011.

The compound

More studies on Linaclotide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking linaclotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo